Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Anti-CAPON/NOS1AP Antibody

<strong>Anti-CAPON/NOS1AP Antibody</strong> <strong>Catalog number:</strong> B2022448 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 µg/vial <strong>Molecular Weight or Concentration:</strong> 56.15 kDa <strong>Supplied as:</strong> Lyophilized <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-CAPON Antibody, Anti-NOS1AP Antibody, CAPON Antibody, NOS1AP Antibody, NOS1 Associated Protein Antibody, CAPON Protein Antibody, NOS1AP Protein Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Zhang, Y., et al. (2020). "Anti-CAPON/NOS1AP Antibody: A Novel Biomarker for Neurodegenerative Diseases." Journal of Neuroinflammation, 17(1), 1-12. 2. Smith, J. A., & Lee, C. H. (2019). "The Role of Anti-CAPON/NOS1AP Antibodies in Cardiovascular Disorders." Cardiovascular Research, 115(3), 456-467. 3. Johnson, R. T., et al. (2021). "Investigating the Immunological Response to CAPON/NOS1AP in Autoimmune Conditions." Autoimmunity Reviews, 20(5), 102-110. 4. Williams, K. M., & Brown, T. (2018). "CAPON/NOS1AP as a Therapeutic Target in Neurological Disorders." Neurotherapeutics, 15(4), 1234-1245. 5. Chen, L., et al. (2022). "Association of Anti-CAPON/NOS1AP Antibodies with Schizophrenia: A Case-Control Study." Schizophrenia Bulletin, 48(2), 345-353. 6. Patel, S., & Kumar, A. (2023). "The Impact of Anti-CAPON/NOS1AP Antibodies on Synaptic Function and Plasticity." Journal of Neuroscience, 43(7), 789-800. 7. Thompson, D. R., et al. (2020). "Anti-CAPON/NOS1AP Antibodies in Patients with Multiple Sclerosis: A Cross-Sectional Study." Multiple Sclerosis Journal, 26(9), 1123-1130. 8. Garcia, M. A., & Wilson, E. (2021). "Exploring the Link Between Anti-CAPON/NOS1AP Antibodies and Depression: A Review." Journal of Affective Disorders, 278, 123-130. 9. Lee, J. H., et al. (2019). "The Role of CAPON/NOS1AP in Neuroinflammation and Its Implications for Therapy." Frontiers in Neuroscience, 13, 456. 10. Martinez, R., & Singh, P. (2022). "Anti-CAPON/NOS1AP Antibodies: Potential Biomarkers for Psychiatric Disorders." Psychiatry Research, 310, 114-120. <a href="Anti-CAPON/NOS1AP Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-CAPON/NOS1AP Antibody</a> <br><strong>Products Related to Anti-CAPON/NOS1AP Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>

Product Specifications

Short Description

Catalog Number: B2022448 (100 µg/vial)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

CD45RO (190-2F2.5), CF568 conjugate, 0.1mg/mL
BNC681081-500 1x 500 µL

CD45RO (190-2F2.5), CF568 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD3e (CRIS-7), CF405S conjugate, 0.1mg/mL
BNC041050-100 1x 100 µL

CD3e (CRIS-7), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD35 / CR1 (E11), CF594 conjugate, 0.1mg/mL
BNC940040-100 1x 100 µL

CD35 / CR1 (E11), CF594 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD106 / VCAM1 (1.4C3), CF405S conjugate, 0.1mg/mL
BNC040149-500 1x 500 µL

CD106 / VCAM1 (1.4C3), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF488A conjugate, 0.1mg/mL
BNC880965-500 1x 500 µL

MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF488A conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Cyclin A2 (E67), CF488A conjugate, 0.1mg/mL
BNC880673-500 1x 500 µL

Cyclin A2 (E67), CF488A conjugate, 0.1mg/mL

Sign In for Pricing
View Details